Skip to main content
Notice2022-11257

Bulk Manufacturer of Controlled Substances Application: Royal Emerald Pharmaceuticals

Primary source

Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.

Published
May 25, 2022

Issuing agencies

Justice DepartmentDrug Enforcement Administration

Abstract

Royal Emerald Pharmaceuticals has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.

Indexed from Federal Register on May 25, 2022.

This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.